Pilot Study AgreementPilot Study Agreement • September 14th, 2005 • Avalon Pharmaceuticals Inc • Pharmaceutical preparations • Delaware
This Agreement is entered into as of September 9, 2005 (the “Effective Date”) by and between Novartis Institutes for BioMedical Research, Inc. (“Novartis”), with an office at 250 Massachusetts Ave., Cambridge, MA 02139, and Avalon Pharmaceuticals, Inc. (“Avalon”), with an office at 20358 Seneca Meadows Parkway, Germantown, MD 20876. Novartis and Avalon are sometimes referred to herein individually as a “Party” and collectively as the “Parties.” A reference to a Party herein includes a reference to its Affiliates (as defined below) unless otherwise indicated.
